RecruitingNot ApplicableNCT06046833

Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes

Glucose Metrics Using Freestyle Libre 3 Real-Time Continuous Glucose Monitor (rtCGM) in Patients With Gastroparesis in Type 1 or Type 2 Diabetes: Investigator Initiated Pilot Study


Sponsor

Samita Garg

Enrollment

50 participants

Start Date

Jan 8, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

A pilot study to evaluate and compare glucose metrics using a real-time continuous glucose monitor (FreeStyle Libre 3 sensor) between patients with diabetes and gastroparesis and those with diabetes without gastroparesis.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study looks at continuous glucose monitoring (CGM) data in people with type 1 or type 2 diabetes who also have a condition called gastroparesis (where the stomach empties food slowly). The goal is to understand how delayed stomach emptying affects blood sugar patterns, to improve diabetes management in this group. **You may be eligible if...** - You are 18 or older - You have type 1 or type 2 diabetes diagnosed for at least 1 year - Your HbA1c (a measure of long-term blood sugar) is 11% or below - You have symptoms and a confirmed diagnosis of gastroparesis (or are in the comparison group without gastroparesis) - You use a continuous glucose monitor (CGM) **You may NOT be eligible if...** - You have had a severe low or high blood sugar event requiring emergency care in the past 2 weeks - Your thyroid function is abnormal (not treated) - You have had gastric surgery that affects stomach emptying Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEFreeStyle Libre 3 continuous glucose monitoring sensor

The Freestyle Libre 3 sensor is a small real-time continuous glucose monitor device that measures glucose levels every minute

OTHERNutritional drink

Balanced nutritional drink (Boost plus 8 ounces/237 mL)


Locations(1)

Cleveland Clinic Foundation

Cleveland, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06046833


Related Trials